Ingersoll Rand Inc. · NYSE:IR
Ingersoll Rand — Gardner Denver Holdings — Q1 2019 Earnings Presentation
15 slides from Ingersoll Rand's earnings presentation, May 3, 2019
Slide 1: Gardner Denver Q1 2019 Earnings Presentation
Gardner Denver Q1 2019 Earnings Presentation April 30, 2019
Slide 2: Replay Information
Replay Information = Dial toll-free: +1.877.344.7529 « International: +1.412.317.0088 * Conference ID: #10130797 « Log on to: http://investors.gardnerdenver.com
Slide 3: Disclaimer
Disclaimer Forward-Looking Statements During the course of this presentation, we may make “forward-looking statements” within the meaning of the US federal securities laws. In fact, all statements made during this presentation other than statements of historical fact are forward-looking statements.
Slide 4: Agenda
Agenda = Company Highlights » Segment Highlights * Guidance * Q&A
Slide 5: Q1 2019 Highlights
Q1 2019 Highlights* Q1 performance consistent with expectations... reaffirming full year 2019 guidance = Revenue of $620M, flat, and up 4% excluding FX * Known pressure in upstream Energy mitigated by the rest of portfolio, including solid performance in mid/downstream Energy businesses = GDP-expose
Slide 6: Our Strategy
Our Strategy & Deploy Talent ) Expand Margins |) Accelerate Growth ‘S) Allocate Capital Effectively Gane
Slide 7: Industrials Segment — Q1 Highlights
Industrials Segment — Q1 Highlights (Dollars in millions) s Prior yor | Ex-FX YOY Reported Year Change Revenue $318.1 $316.9 0.4% Adjusted EBITDA $71.0 $66.8 6.3% 12.0% Adjusted EBITDA Margin 22.3% 21.1% 120 bps Innovation in Action ighlights: * Orders up 4% ex-FX + Revenue up 6% exFX + Strong broad
Slide 8: Energy Segment — Q1 Highlights
Energy Segment — Q1 Highlights (Dollars in millions) As Prior Reported Year Revenue $233.1 $242.2 (3.8)% (1.1)% Adjusted EBITDA $60.0 $68.0 (11.8)% (10.4)% Adjusted EBITDA Margin 25.7% 28.1% (240) bps Innovation in Action Highlight = Orders down 26% ex-FX = Revenue down 1% ex-FX = Upstream revenue d
Slide 9: Medical Segment — Q1 Highlights
Medical Segment — Q1 Highlights (Dollars in millions) Prior Yoy Ex-FX YOY Reported Year Change Chang Revenue $69.1 $60.5 14.2% 19.1% Adjusted EBITDA $20.0 $15.9 25.8% 32.1% Adjusted EBITDA Margin 28.9% 26.3% 260 bps Innovation in Action Highlights: "Orders down 1% ex-FX... on top of 11% growth in pr
Slide 10: Reaffirming 2019 Guidance
Reaffirming 2019 Guidance Revenue Adjusted Phasing Growth? EBITDA Revenue Growth! Excluding impact of F) Industrials up MSD Medical up MSD Mid and Downstream Energy up MsD Upstream Energy down LDD to HSD Corporate - (Before PX8 Other Corporate Expense) —_—_—UPLSDIOMSD “STR STO fase soto mo $680M - $
Slide 11: Reaffirming 2019 Guidance (continued)
Reaffirming 2019 Guidance (continued) Capital Expenditures ~$50M - $60M Tax Rate 24% to 26% Year End Net Debt Leverage" 15x to 1.7x Average Shares Outstanding? ~208M
Slide 12: Appendix
Appendix
Slide 13: Reconciliation of Net Income and Earnings per Share to Adjusted Net Income and Adjusted EPS
Reconciliation of Net Income and Earnings per Share to Adjusted Net Income and Adjusted Earnings per Share
Slide 14: Reconciliation of Net Income to Adjusted EBITDA and Free Cash Flow
Reconciliation of Net Income to Adjusted EBI Net Income and CFOA to Free Cash Flow “GARONER DENVER HOLDINGS INC. AND SUBSIOIARES INCOME AND CASH FLOWS - OPERATING ACTIVITIES TO FREE CASH FLOW (Gollan muons) (unauates) A and Adjusted “
Slide 15: Reconciliation of Segment Adjusted EBITDA to Income/(Loss) Before Income Taxes
Reconciliation of Segment Adjusted EBITDA to Income/(Loss) Before Income Taxes
Gardner Denver Holdings — Q1 2019 Earnings Presentation on 6ix